Corient Private Wealth LLC Sells 157,534 Shares of Option Care Health, Inc. $OPCH

Corient Private Wealth LLC trimmed its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 84.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,896 shares of the company’s stock after selling 157,534 shares during the period. Corient Private Wealth LLC’s holdings in Option Care Health were worth $953,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the stock. V Square Quantitative Management LLC bought a new stake in shares of Option Care Health in the 4th quarter valued at about $25,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health in the third quarter worth approximately $35,000. McIlrath & Eck LLC acquired a new position in shares of Option Care Health in the second quarter worth approximately $37,000. Caitong International Asset Management Co. Ltd bought a new stake in Option Care Health in the third quarter valued at approximately $38,000. Finally, Quarry LP boosted its holdings in Option Care Health by 502.7% in the third quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after acquiring an additional 1,292 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CEO John Charles Rademacher purchased 12,500 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the purchase, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the business’s stock in a transaction on Monday, May 4th. The stock was purchased at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the acquisition, the director owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. This represents a 8.86% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have bought 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is owned by company insiders.

Option Care Health Trading Up 4.1%

NASDAQ:OPCH opened at $21.90 on Friday. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The stock has a market capitalization of $3.44 billion, a price-to-earnings ratio of 16.98, a PEG ratio of 1.17 and a beta of 0.65. The firm has a fifty day simple moving average of $21.80 and a two-hundred day simple moving average of $28.31. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $26.00 price target on shares of Option Care Health in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their price objective on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. TD Cowen dropped their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Zacks Research downgraded Option Care Health from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Finally, Stephens set a $30.00 price objective on Option Care Health in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.